Pembrolizumab,Vibostolimab,Favezelimab
merck
['key,note,045', 'mibc', 'pembro', 'key,note,45', 'key,note,57', 'nmibc', 'thanks', 'bladder', ' uc,(-ucsd),(-ucsf),']
thanks necchi, md showing us that pembro showed notable antitumor activity in pts with bcg-unresponsive non-cis papillary hr nmibc after ~45 mo of follow-up. rlts suggest pts with non-cis papillary hr nmibc unresponsive to bcg may also benefit from pembro montx
#ascogu2023 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.